📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualification (2021)

First Author: Sowalsky A

Attributed to: BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ctarc.2020.100218

PubMed Identifier: 33516656

Publication URI: http://europepmc.org/abstract/MED/33516656

Type: Journal Article/Review

Parent Publication: Cancer Treatment and Research Communications

ISSN: 2468-2942